Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

CompanDX, a UK Biomarker Startup, Raises $6.1 Million from China

publication date: Aug 28, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
CompanDX, a UK diagnostic startup, raised $6.1 million (39.6 million RMB) from China sources, the money coming from a combination of government and private investors. The company has developed bioinformatics algorithms to identify the group of patients that will respond to a particular therapy. The investment makes the China investors eligible to receive a percentage of the royalties developed with the capital, but it does not purchase equity in the company – a non-dilutive financing. CompanDX had presented at the ChinaBio Investor Forum in BioBay (Suzhou) last September. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...